Drugs Against Tropical Protozoan Parasites: Target Selection, Structural Biology, and Rational Medicinal Chemistry
joint with Malaria's Challenge: From Infants to Genomics to Vaccines
Organizer(s): Michael H. Gelb and Wim G.J. HolDate: March 03 - 08, 2002
Location: Keystone Resort, Keystone, CO, USA
Diseases in humans caused by protozoa lead to suffering in hundreds of millions of people worldwide. We are approaching a time when the genomes of organisms responsible for diseases such as malaria, sleeping sickness, and leishmaniasis are fully sequenced. This provides an optimal setting for the discovery and evaluation of new drug targets, especially when combined with structural biology, combinatorial chemistry, and parasite genetics. Effective drugs are lacking for diseases including sleeping sickness and leishmaniasis, and current therapies for treating malaria are at risk due to the emergence of drug resistance. Thus, the development of new lines of anti-protozoan agents is urgently needed. Groups of talks, one or two given by the chemist/structural biologist and the other by the parasitologist, will exemplify the power of multi-disciplinary collaborations. We will also invite people outside of parasitology in an effort to stimulate their interests in tropical medicine.
Discounted Abstract Deadline: November 16 2001
Discounted Registration Deadline: January 3 2002